It is very uncertain whether summary of findings table ‐ Metformin + megestrol changes hysterectomy rate compared with megestrol (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether overall analyses: second‐generation endometrial ablation changes bleeding compared with first‐generation endometrial ablation (very low certainty).
Overall analyses: second‐generation endometrial ablation showed no clear difference in satisfaction rate compared with first‐generation endometrial ablation (low certainty).
It is very uncertain whether overall analyses: second‐generation endometrial ablation changes proportion given local anaesthesia (%) compared with first‐generation endometrial ablation (very low certainty).
Overall analyses: second‐generation endometrial ablation showed no clear difference in complication rate ‐ perforation compared with first‐generation endometrial ablation (low certainty).
Overall analyses: second‐generation endometrial ablation showed no clear difference in requirement for additional surgery compared with first‐generation endometrial ablation (low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes hysterectomy rate compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes abnormal uterine bleeding compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ all effects compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ nausea compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ heaviness in lower abdomen compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ pain in abdomen compared with levonorgestrel intrauterine system (very low certainty).
It is very uncertain whether pentoxifylline changes recurrence rate of endometriosis compared with placebo (very low certainty).
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
It is very uncertain whether metformin changes clinical pregnancy rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (very low certainty).
Metformin showed no clear difference in miscarriage rate per woman compared with placebo or no treatment (low certainty).